By transplanting PKM2-knockdown HCCLM3 cells into mice, it was found that tumor progression was significantly inhibited and the percentage of CD11b+Gr-1+ granulocytic MDSCs and CD11b+Ly6C+ monocytic MDSCs were decreased obviously when compared with HCCLM3 transplanted mice. This evidence concerns the gene ITGAM and neoplasm.